New dextran derivatives. I. Nitrogen containing derivatives. 1983

J Z Mioduszewski, and L Halski, and M Mioduszewska

Three new derivatives of dextran were obtained: 3-morpholine-2-hydroxypropyl ether of dextran (I), hydroxamic acid of carboxymethyl dextran (II), and oxime of ketodextran (III). All the three derivatives exhibited low toxicity at parenteral administration to laboratory animals. (I) and (II) showed the capability of weakening the activity of tetanus and malignant edema toxins. Additionally, (I) showed immunotropic activity. Biological activity was observed when the derivative (I) had been obtained from dextran of the molecular weight 4000. At the molecular weight 20,000 the activity did not appear. Similarly, no activity was observed under oral administration.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

J Z Mioduszewski, and L Halski, and M Mioduszewska
July 1969, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J Z Mioduszewski, and L Halski, and M Mioduszewska
March 1973, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J Z Mioduszewski, and L Halski, and M Mioduszewska
February 1966, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J Z Mioduszewski, and L Halski, and M Mioduszewska
June 1951, Cancer research,
J Z Mioduszewski, and L Halski, and M Mioduszewska
June 1967, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J Z Mioduszewski, and L Halski, and M Mioduszewska
June 1969, Mitteilungen. Deutsche Pharmazeutische Gesellschaft,
J Z Mioduszewski, and L Halski, and M Mioduszewska
January 1971, Farmakologiia i toksikologiia,
J Z Mioduszewski, and L Halski, and M Mioduszewska
March 2016, Angewandte Chemie (International ed. in English),
J Z Mioduszewski, and L Halski, and M Mioduszewska
June 2018, Data in brief,
Copied contents to your clipboard!